COMPLEMENT COMPONENT 2 DEFICIENCY
|
disease |
|
Disease or Syndrome
|
11
|
4
|
0.770 |
strong |
0.900 |
10 |
4
|
1975 |
2010 |
Polypoidal choroidal vasculopathy
|
disease |
|
Disease or Syndrome
|
56
|
67
|
0.030 |
None |
1.000 |
3 |
3
|
2012 |
2015 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
2 |
4
|
2018 |
2018 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Lean body mass
|
phenotype |
|
Clinical Attribute
|
144
|
211
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
mathematical ability
|
phenotype |
|
Mental Process
|
854
|
2127
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
149
|
527
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
147
|
526
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
von Willebrand's factor (lab test)
|
phenotype |
|
Laboratory Procedure
|
55
|
427
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Myeloperoxidase Measurement
|
phenotype |
|
Laboratory Procedure
|
15
|
16
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
MACULAR DEGENERATION, AGE-RELATED, 14
|
disease |
|
Disease or Syndrome
|
2
|
|
0.300 |
None |
|
0 |
|
|
|
Intelligence
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental Process
|
645
|
2093
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.100 |
None |
1.000 |
3 |
3
|
2017 |
2018 |
Isomerism (body)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Congenital Abnormality
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Angioedemas, Hereditary
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases; Immune System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
54
|
7
|
0.020 |
None |
0.500 |
2 |
|
1983 |
1985 |
Abdominal bloating
|
phenotype |
Digestive System Diseases
|
Sign or Symptom
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hepatitis B, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
415
|
84
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.110 |
None |
1.000 |
2 |
2
|
1984 |
2013 |
Liver neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1424
|
7
|
0.010 |
None |
1.000 |
1 |
|
1984 |
1984 |